FDA approves landmark pancreatic cancer drug that's shown to improve survival AP NewsF.D.A. Approves the Drug Daraxonrasib That's Poised to Transform Pancreatic Cancer The New York TimesFDA approves breakthrough drug daraxonrasib to treat pancreatic cancer BBCFDA approves once-daily pill for deadly cancer after patients' survival rates nearly double Fox News
